TheProfitWatch

OCGN - Ocugen, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.71 -0.06 (-3.5%) --- 0.0 (0.0%) -0.01 (-0.6%) -0.07 (-4.09%) 0.01 (0.61%) -0.01 (-0.6%) -0.01 (-0.6%)

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
1.65
RVol:

Events

Period Kind Movement Occurred At

Related News